Flavio Luciano Ribichini
Flavio L. Ribichini graduated in Medicine at the National University of Cordoba, Argentina, and board certificated in Cardiology at the University of Torino.
He trained in interventions at the University of Paris VII, Stanford University, Mount Sinai Medical School, New York and was Research Fellow of the ESC in Aalst, Belgium.
Proficient in Spanish, Italian, English, Portuguese and French.
EDUCATION RESPONSIBILITIES AND MEETING ORGANISATION
- Full Professor of Cardiovascular Medicine at the University of Verona and Director of the School of Cardiovascular Medicine and Head of the Cardiology training program and the Master in Interventions of the University.
- Director of the Heart Lung and Vascular Department of Verona Hospitals.
- Member of the Editorial Board of the EHJ and Senior Associate Editor of the International Journal of Cardiology.
- Since 2000 is member of the scientific board of PCR.
- Since 2024 is the Secretary of the EAPCI of the ESC and co-Director of the Department of Medicine.
- Co-Director of CITIC in Mexico.
- Co-Director of the PCR Rio Valves Course.
- Co-Director of the PCR Focus Group on Cardiac Mechanical Support.
ACTIVE AREAS OF RESEARCH
- In more than 30 years of interventional cardiology, education and research he has worked in coronary, peripheral, congenital and structural fields, with particular dedication to medical education and post-graduate training and has contributed to the preparation of Guidelines and Consensus Documents of the ESC.
- Author of over 490 full publications on clinical and basic research available in PubMed
Diplomas
| Year | Diploma |
|---|---|
| 1986 | Doctor of Medicine - National University of Cordoba, Argentina |
Latest contributions
New DCB indications for everyday practice
26 Aug 2025
Register for free to this webinar on 14 October at 5:00pm (UTC+2) with F. Ribichini, M. Götberg, B. Khialani and B. Vaquerizo and learn to review the newest indications for the use of DCB: focus on STEMI, CTO, bifurcations and calcified lesions...
Early invasive treatment for aortic stenosis?
25 Jul 2025
Watch this replay with F. Ribichini, P. Caramori and C. Zukowski to discuss on how symptom status can be assessed, and how imaging supports the selection of asymptomatic patients for TAVR and so much more!
A Multidisciplinary Core Team
12 Jun 2025
The three Directors have different specialties: Robert Lorusso is a cardiac surgeon, Sascha Ott a cardiac intensivist and Flavio Ribichini a interventional cardiologist. 40 other healthcare practitioners will be assigned to one of 5 working groups:
- Patient and MCS device phenotyping
- Implantation and complication management
- Shock network and patient...
EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
How to efficiently and safely manage calcified left main disease?
21 May 2025 – From EuroPCR 2025
Nicola Ryan and Flavio Ribichini explore the complexities of calcified left main stem disease, emphasizing the critical role of intracoronary imaging in improving patient outcomes. They discuss the practical use of mechanical circulatory support and debate stenting strategies, offering expert insights on when single or dual...
FAITAVI - Major Late-Breaking Trial from EuroPCR 2025
22 May 2025 – From EuroPCR 2025
Presented at EuroPCR 2025, the FAITAVI trial brings new insights into the management of coronary artery disease in patients undergoing TAVI.
In this PCR Perspectives video, Stephan Windecker and Flavio Ribichini explore how the trial—the first of its kind—compared angiography-guided versus FFR-guided strategies for intermediate coronary lesions....
EuroPCR 2025 – The place to share solutions
07 May 2025
The annual World-Leading Course in interventional cardiovascular medicine is the official meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI). Thousands of participants will once again be gathering to share their knowledge, skills and experience on 20-23 May 2025, at the Palais des Congrès in...
Stent or Leave: considerations for a successful DCB PCI
27 Feb 2025
Watch the replay webinar with F. Ribichini, F. Jafary, Y. Onuma and B. Scheller to learn how to “control” dissections during lesion preparation, and much more!
Best of science and education in cardiovascular interventional medicine in 2024
16 Dec 2024
Dear Colleagues, dear PCR Companions,
As we welcome a new year, it is the perfect time to reflect on what we achieved together over the past year—both as a celebration of our successes and as motivation to continue improving in the year ahead.
2024 was a record year...
“BIO-PCI” the turning point of vascular interventions?
03 Dec 2024
Discuss the rationale of a PCI strategy with minimal metal as a turning point of vascular interventions with Flavio Luciano Ribichini, Salvatore Brugaletta and Piera Capranzano.
Hostile iliac access managed with IVL - How far can we go?
10 Oct 2024
Analyze this case to find out how to successfully manage a patient with severe aortic stenosis and severely calcified peripheral vasculature referred to transcatheter aortic valve implantation.
Author
Author
Euro4C Team
19 Jun 2024
Discover the individuals driving the Euro4C Group, including the main board, national coordinators, research and education groups, and the dedicated editorial team!
uRDN now - The third pillar for hypertension treatment
16 May 2024 – From EuroPCR 2024
Tune into this session to stay updated on the cutting-edge clinical evidence, guidelines, and technology surrounding renal denervation. Explore firsthand clinical experiences with ultrasound renal denervation and gain practical insights into patient selection through individual, real-world case discussions. Engage in discussions on integrating ultrasound renal denervation...
Essentials in the management of calcified coronary stenosis
16 May 2024 – From EuroPCR 2024
This session focuses on the essentials of managing calcified coronary stenosis, including diagnostic pitfalls, selection strategies for appropriate plaque modification devices, and the safe and effective adoption of specific tools and techniques. Through interactive case discussions, attendees will learn how to effectively evaluate and treat calcified...
Valvular and structural interventions
16 May 2024 – From EuroPCR 2024
This session features presentations and discussions on various novel transcatheter technologies for valvular and structural heart interventions. It includes a novel transcatheter tricuspid repair technology, a new endovascular aortic root and total arch stent-graft replacement system, a novel self-expandable transcatheter aortic valve, and a transcatheter mitral...
Restoring vessel physiology drives outcomes - The Bioadaptor experience
16 May 2024 – From EuroPCR 2024
Join this session to delve into the unmet needs concerning drug-eluting stents (DES), including poor long-term clinical outcomes, with up to a 50% MACE rate at 10 years, and a non-plateauing 2-3% annual event rate. Explore how DynamX Bioadaptor technology addresses these challenges by maintaining the...
How do I confidently expand my DCB practice?
15 May 2024 – From EuroPCR 2024
This session offers insights on identifying appropriate lesions for DCB treatment, understanding the essential concepts for achieving optimal immediate results with DCB PCI, and exploring the long-term angiographic and clinical outcomes. The session emphasizes the importance of lesion preparation, notes that there are no contraindications for...
The turning point in hypertension care: Symplicity Spyral renal denervation in practice
15 May 2024 – From EuroPCR 2024
Explore this session to grasp the FDA-approved status of renal denervation, its safety and efficacy shown in numerous studies with lasting effects, and the importance of multidisciplinary discussions for successful indications. Consult also the session for updated recommendations on renal denervation in hypertension treatment guidelines, procedural safety...
Renal denervation step by step: how to perform a safe and effective procedure
14 May 2024 – From EuroPCR 2024
This session provides a comprehensive overview of renal denervation, covering the essential aspects of patient selection, preprocedural assessment and imaging, the technical steps for performing safe and effective radiofrequency and ultrasound-based renal denervation, and the importance of post-procedural follow-up. The discussions aim to equip the audience...
How to overcome the most clinically relevant challenges in TAVI
14 May 2024 – From EuroPCR 2024
Watch this session to discover insights into patient-prosthesis mismatch and strategies to mitigate risks, delve into the significance of aortic valve commissure for coronary alignment optimization during TAVI, and explore solutions for common TAVI challenges such as peripheral vessel tortuosity and asymmetric valve calcifications in large...
Role of deferred stenting in culprit and non-culprit lesions for STEMI
14 May 2024 – From EuroPCR 2024
This session explores the role of deferred stenting in STEMI patients, covering when and how PCI can be deferred, the latest pharmacological options for deferred stenting, and the use of imaging and physiology to guide revascularization in a primary PCI setting. Through case presentations and discussions,...
How will the SMART trial results impact our practice and decision making in TAVI?
16 May 2024 – From EuroPCR 2024
Sabine Bleiziffer and Didier Tchétché discuss the SMART trial with Flavio Ribichini in this #europcr 2024 roundtable. The trial compares the self-expandable supra-annular EVOLUT platform and the balloon-expandable intra-annular SAPIEN platform in patients with small aortic annulus, prevalent in up to 40% of Europeans, mainly women....
How should we manage calcific coronary disease according to the European Consensus document?
15 May 2024 – From EuroPCR 2024
Follow this exchange between James Spratt and Flavio Ribichini for insights into how the European Consensus document offers practical guidance for approaching calcified lesions, the significance of angiography findings, the critical role of intravascular imaging (IVUS or OCT), and device selection based on lesion type. Training...
Treating patients with drug-coated balloons – what is the optimal result?
12 Apr 2024
Watch this webinar with F. L. Ribichini, F. Alfonso, C. C. Frankie Tam and A. G. Zaman on how to prepare lesions for drug-coated ballons-based PCI and much more!
Why and when to use DCB?
06 Mar 2024
Watch the replay of this webinar to discuss why a PCI strategy without implantation of metallic stents may be a valid alternative and wich is the supporting evidence.
TAVI in complex scenarios - Prevention and management of acute coronary obstruction
20 Nov 2023 – From PCR London Valves 2023
Although acute coronary obstruction remains rare, it is a dramatic complication during TAVI: find out how to predict this preventable obstruction in different clinical scenarios by learning the key steps of the chimney stenting and BASILICA techniques, and get a glimpse into the future to learn...
Leaflet modification techniques
20 Nov 2023 – From PCR London Valves 2023
Discover cutting-edge leaflet modification approaches in transcatheter interventions with this selection of cases: explore the imaging aspects of the emerging ShortCut procedure for coronary protection in Valve-in-Valve TAVR, experience the effectiveness and simplicity of Balloon - Basilica for valve-in-valve interventions, learn about the adaptability of right...
TAVI durability and potential future solutions - LIVE case
19 Nov 2023 – From PCR London Valves 2023
In this session, you will learn more about the potential technical challenges associated with second-time TAVI procedures, and the importance of detailed CT imaging and careful pre-procedural planning. Discover the latest innovations and future direction of this key area of development.
- Live case: An 83-year-old woman with type 2 diabetes, COPD...
The unimaginable evolution of interventional cardiology from imagination to imaging
07 Nov 2023
Faith is to believe what you do not see; the reward of this faith is to see what you believe... Read this editorial by Flavio Ribichini, Martine Gilard and Salvatore Brugaletta which introduces this section dedicated to cardiovascular imaging. ...
